Skip to main content
OpenTrials

Clinical trial condition

Cholangitis, Sclerosing

Explore clinical trials studying Cholangitis, Sclerosing. Study availability and eligibility vary by location and protocol.

109 public trials 28 recruiting studies
Refine in advanced search Browse all conditions

Cholangitis, Sclerosing trial results

Completed

Obeticholic Acid (OCA) in Primary Sclerosing Cholangitis (PSC)

NCT02177136

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholangitis, +3 more
Locations
  • St. Joseph's Hospital & Medical Center Phoenix, Arizona, United States
  • Mayo Clinic Phoenix, Arizona, United States
  • University of California Davis Medical Center Sacramento, California, United States
  • University of Colorado, Denver Aurora, Colorado, United States
View all 36 locations
View Trial Details
Completed

Study to Evaluate the Safety, Tolerability, and Efficacy of Cilofexor in Adults With Primary Sclerosing Cholangitis Without Cirrhosis

NCT02943460

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholangitis, +3 more
Locations
  • University of California, Davis Medical Center Sacramento, California, United States
  • University of California San Francisco San Francisco, California, United States
  • University of Colorado Denver Aurora, Colorado, United States
  • Florida Digestive Health Specialists Lakewood Rch, Florida, United States
View all 23 locations
View Trial Details
Completed

Simtuzumab (GS-6624) in the Prevention of Progression of Liver Fibrosis in Adults With Primary Sclerosing Cholangitis (PSC)

NCT01672853

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholangitis, +9 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • University of Arizona Health Sciences Center Tucson, Arizona, United States
  • Southern California Liver Center Chula Vista, California, United States
  • Southern California Liver Centers Coronado, California, United States
View all 75 locations
View Trial Details

Related conditions